Related Experiment Video

Updated: Aug 20, 2026

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
09:24

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells

Published on: May 9, 2020

[Specific inhibition of hTERT gene expression by short interfering RNAs in gastric cancer SGC7901 cell]

Jin-Ping Ma1, Wen-Hua Zhan, Jian-Ping Wang

  • 1Department of General Surgery, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.

Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|January 7, 2005
PubMed
Abstract

Insights

Short hairpin RNAs (shRNAs) effectively silenced the human telomerase (hTERT) gene in gastric cancer cells. This demonstrates the potential of shRNA technology for cancer gene therapy.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Context:

  • Human telomerase catalytic subunit (hTERT) activation is crucial for cancer cell proliferation.
  • Gastric cancer cells (SGC7901) exhibit elevated hTERT expression.
  • RNA interference (RNAi) offers a potential strategy for gene silencing.

Purpose:

  • To investigate the efficacy of small interference RNA (siRNA) in suppressing hTERT gene expression in SGC7901 cells.
  • To validate the use of a short hairpin RNA (shRNA) expression vector for targeted gene knockdown.
  • To assess the feasibility of U6 promoter-driven shRNA for cancer gene therapy.

Summary:

  • A pilot study utilized a green fluorescent protein (GFP) reporter system to confirm shRNA efficacy.
  • Constructed pU6-hTERT-siRNAs successfully targeted and inhibited hTERT gene expression in SGC7901 cells.
  • Reverse transcription polymerase chain reaction (RT-PCR) and fluorescence quantitative polymerase chain reaction (FQ-PCR) confirmed gene silencing.

Impact:

  • Demonstrates sequence-specific hTERT gene silencing in gastric cancer cells using shRNAs.
  • Establishes the feasibility of U6 promoter-driven shRNA expression for cancer gene therapy.
  • Provides a foundation for developing novel therapeutic strategies targeting hTERT in cancer.

More Related Videos

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents09:18

TRUE Gene Silencing: Screening of a Heptamer-type Small Guide RNA Library for Potential Cancer Therapeutic Agents

Published on: June 2, 2016

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...